Most musculoskeletal radiologists prefer to use MRI in their daily practice even though they recognize the value of ultrasound to evaluate and diagnose many MSK conditions, according to results of a survey presented at the 2004 RSNA meeting.
Most musculoskeletal radiologists prefer to use MRI in their daily practice even though they recognize the value of ultrasound to evaluate and diagnose many MSK conditions, according to results of a survey presented at the 2004 RSNA meeting.
Dr. Sandra Allison and colleagues at Thomas Jefferson University sent a questionnaire via e-mail to 300 members of the Society of Skeletal Radiology and to 105 members of the Society of Radiologists in Ultrasound. The 110 radiologists who responded (25%) had on average 13 years of experience.
More than three-quarters of respondents said that MRI should be the modality of choice to evaluate tendon, ligament, and muscle injuries. Two-thirds, however, indicated that too few musculoskeletal ultrasound examinations were ordered, and 80% of those said that reimbursement for MSK ultrasound is too low.
Almost 70% reported that their MSK ultrasound training was inadequate, while two-thirds indicated that ultrasound required too much physician time.
The survey also accounted for the specialists' respective biases. Sonologists were more likely to favor ultrasound, while musculoskeletal radiologists preferred MRI, the researchers said.
For more information from the Diagnostic Imaging archives:
Microgravity shoulder scan makes ultrasound history
Brazilian radiologists take on soccer injuries
Slim-line probes aid hand and wrist scans
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.